Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AMLODIPINE AND OLMESARTAN MEDOXOMIL

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Standard Dose
5MG/40MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview AMLODIPINE AND OLMESARTAN MEDOXOMIL is listed in Drugs@FDA under application 090398 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Form and strength TABLET; ORAL - 5MG/40MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2011-03-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMLODIPINE AND OLMESARTAN MEDOXOMIL is listed in Drugs@FDA under application 090398 (ANDA). Marketing status: None (Tentative Approval) Active ingredient AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL Form and strength TABLET; ORAL - 5MG/40MG Sponsor MATRIX LABS LTD Submission history Latest submission status date: 2011-03-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.